J9017 HCPCS code: Injection, arsenic trioxide, 1 mg
J9017 is the HCPCS Level II code for injection, arsenic trioxide, 1 mg. In 2024 Medicare paid an average of $9.36 per service for J9017 across 36,889 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 30 per day on outpatient hospital claims. Medicare volume rose 58% from 2022 to 2024 (23,388 to 36,889 services). In 2024, about 261 clinicians billed Medicare for J9017 for 51 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1D — Chemotherapy |
| Added | 2002-01-01 |
| Last action effective | 2009-01-01 |
Who bills J9017 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 261 |
| Medicare beneficiaries | 51 |
| States with claims | 0 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9017, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 23,388 | 41 | $13.45 | $10.72 |
| 2023 | 30,383 | 47 | $14.80 | $11.79 |
| 2024 | 36,889 | 51 | $11.79 | $9.36 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 30 | Clinical: Data |
| practitioner claims | 30 | Clinical: Data |
What changed for J9017
- 2002-01-01: J9017 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9017?
J9017 is the HCPCS Level II code for injection, arsenic trioxide, 1 mg. Short descriptor: "Arsenic trioxide injection".
How much does Medicare pay for J9017?
In 2024, the average Medicare payment was $9.36 per service (average allowed $11.79).
Does Medicare cover J9017?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J9017 can be billed per day?
30 on outpatient hospital claims; 30 on practitioner claims (NCCI medically unlikely edits).
Related J90 codes
- J9000 — Injection, doxorubicin hydrochloride, 10 mg
- J9003 — Leuprolide injectable (camcevi etm), 1 mg
- J9010 — Injection, alemtuzumab, 10 mg
- J9011 — Injection, datopotamab deruxtecan-dlnk, 1 mg
- J9015 — Injection, aldesleukin, per single use vial
- J9019 — Injection, asparaginase (erwinaze), 1,000 iu
- J9020 — Injection, asparaginase, not otherwise specified, 10,000 units
- J9021 — Injection, asparaginase, recombinant, (rylaze), 0.1 mg
- J9022 — Injection, atezolizumab, 10 mg
- J9023 — Injection, avelumab, 10 mg
- J9024 — Injection, atezolizumab, 5 mg and hyaluronidase-tqjs
- J9025 — Injection, azacitidine, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9017
- Watch J9017 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9017
Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.